S100A4 and breast carcinoma: In this context, an anti-S100A4 antibody, named 6B12, showed immunomodulatory activity by binding S100A4 and thereby preventing T-cell attraction to the tumour side, which reduced metastasis in lung and breast cancer within experimental mouse models [232,233].